Faculty Research Seminar: Personalised medicine for ovarian cancer
| Dates: | 14 December 2016 |
|---|
| Times: | 12:30 - 14:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| Who is it for: | University staff, Adults, Alumni, Current University students |
|---|
| Speaker: | Professor Stephen Taylor, Dr Gemma Owens |
|---|
|
"Personalised medicine for ovarian cancer"
Professor Stephen Taylor, Leech Professor of Pharmacology, Manchester Cancer Research Centre
Stephen completed his Bachelor’s degree at the University of Manchester and then moved to the University of Oxford to pursue his PhD with Professor Ed Southern, working on mammalian chromosome structure. In 1995, Stephen moved to Harvard Medical School on a Wellcome Trust fellowship. Working with Professor Frank McKeon he discovered components of the mammalian spindle checkpoint. This launched his independent career and in 1998, Stephen moved back to Manchester as a BBSRC David Phillips Fellowship. From 2004 to 2015 he was a CRUK Senior Fellow and was promoted to Professor of Cell Biology in 2009. He won the University’s Kilburn-Williams Medal in 2009 and in 2015 Stephen was awarded the Leech Chair in Pharmacology.
Dr Gemma Owens, Clinical Research Training Fellow, Manchester Cancer Research Centre
Gemma Owens is a Clinical Research Fellow and Registrar in Obstetrics and Gynaecology. Gemma completed her medical degree and a BSc in Pathology at Queen's University Belfast. Following graduation, Gemma completed her foundation training at the Royal Preston Hospital. During this time, she completed a 4-month research project investigating the role of blood based infrared spectroscopy in the diagnosis of ovarian cancer at the University of Lancaster. In 2012, Gemma moved to Manchester after securing a NIHR Academic Clinical Fellowship (ACF). Gemma is currently taking time away from clinical practice to complete a Clinical Research Fellowship funded by MCRC/CRUK. Gemma's current research focuses on developing adoptive cell therapy using tumour-infiltrating lymphocytes (TILs) as a personalised treatment strategy for epithelial ovarian cancer.
Lunch is available 12.30-1pm; presentations run 1-2pm.
Registration is recommended and can be made via Eventbrite, or by contacting lorna.tittle@manchester.ac.uk.
Details of the full series can be found on the Faculty Research Series page on FBMH Staffnet.
Speakers
Professor Stephen Taylor
Role: Leech Professor of Pharmacology
Organisation: Manchester Cancer Research Centre
Dr Gemma Owens
Role: Clinical Research Training Fellow
Organisation: Manchester Cancer Research Centre
Travel and Contact Information
Find event
Michael Smith Lecture Theatre
Michael Smith Building
Manchester
